Regular aspirin use may reduce risk of cancer metastasis

Daily aspirin may prevent distant cancer metastasis, according to a recent analysis.

Researchers from the United Kingdom examined 5 large, randomized trials (17,285 participants) of daily aspirin (≥75 mg daily) vs control for the prevention of vascular events to assess the effect of aspirin on the frequency of distant metastasis in patients who developed cancer during the trials. Participants were followed for an average of 6.5 years.

Patients assigned to daily aspirin in these trials had a 36% reduction in their risk of metastatic cancer and a 46% reduction in their risk of adenocarcinomas. This finding suggests that...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Non-Communicable Disease, Oncology, Pharmacology, Primary Care and tagged , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.